MDM2 and lipoma: The definitive diagnosis was achieved through histopathological examination (atypical stromal cells in fibrous septa) combined with molecular testing (MDM2/CPM amplification), emphasizing the need for vigilance regarding the dual clinical features of age > 50 years coupled with infiltrative growth in atypical lipoma-like masses.